Orchid Pharma Limited (NSE: ORCHPHARMA) has submitted a transcript of its recent Analysts/Institutional Investor Meet on the National Stock Exchange.
Orchid Pharma Limited has released a transcript from its recent analyst and institutional investor meeting via NSE filing.
Orchid Pharma Limited has informed the NSE about a transcript disclosure from its recent analyst or institutional investor meeting, offering transparency for stakeholders.
Orchid Pharma Limited has notified the National Stock Exchange about a transcript related to an analyst or institutional investor meeting or conference call, according to an exchange filing.
Orchid Pharma Limited has informed the exchange about transcript availability from an institutional investor engagement, signalling continued communication with market participants.
Orchid Pharma Limited has filed a transcript notification with NSE regarding an analysts and institutional investor meet or conference call.
Orchid Pharma Limited has filed a transcript from its recent analysts and institutional investor meet with the NSE, providing investors access to discussions from the corporate engagement.
Orchid Pharma Limited notified the NSE about availability of analyst and institutional investor meet transcript, signaling regular market engagement.
Orchid Pharma Q3 FY25 Results
Orchid Pharma Q2 FY25 Results
Orchid Pharma Q3 FY24 Results
NSE & BSE filings, earnings, insider trades, and smart volume alerts — on WhatsApp or Telegram. No separate app to install.